<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230809059091N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-08-16</date_registration>
      <primary_sponsor>CMH Rahim Yar Khan</primary_sponsor>
      <public_title>PENG VERSUS FIB</public_title>
      <acronym></acronym>
      <scientific_title>COMPARISON OF THE NOVEL PENG (PERICAPSULAR NERVE GROUP) BLOCK VERSUS FASCIA ILIACA BLOCK (FIB) IN PATIENTS UNDERGOING TOTAL HIP ARTHROPLASTY</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-08-09</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>150</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/71923</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Non-probability consecutive sampling by lottery method into the two interventional groups, Blinding description: Single blind with the patient unaware of the block type done.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Pain with total hip arthroplasty due to osteoarthritis.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Group F (Fascia iliac block group) will receive the block pre-operatively in the operating room with the patient unaware of the block performed by a consultant anesthetist with at least 5 years of experience under ultrasound guidance administering 20 ml of local anesthetic (2% ligonicaine) in the facia iliac plane. After surgery median pain scores assessment would be done by standard visual analog scale at 3,6,12 and 24 hour duration along with time to patient mobilization. Intervention 2: Intervention group: Group P (pericapsular nerve group block) will receive the block pre-operatively in the operating room with the patient unaware of the block performed by a consultant anesthetist with at least 5 years of experience under ultrasound guidance administering 20 ml of local anesthetic (2% ligonicaine) in the pericapsular space and blocking corresponding nerves. After surgery median pain scores assessment would be done by standard visual analog scale at 3,6,12 and 24 hour duration along with time to patient mobilization.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Output SPSS sheets and all excel data sets

When:
After approval of the manuscript by the journal

To whom:
Everyone open access

Conditions:
The study data including excel sheets and SPSS output files can be used after permission from the primary author who would receive the application for data use via email

Where to obtain:
The data will be uploaded on the Google drive of the primary author with the email (nabeel4allz@gmail.com) and will be available after a formal email request

How to obtain:
A formal email on the address given to the primary author of the article. Any queries asked by the author would be done through email and link to the data from google drive would be sent after author approval (usual time till approval is 7 days)

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Nabeel Butt</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Chowk Bahadarpur</address>
        <city>Rahim Yar Khan</city>
        <country1>Pakistan</country1>
        <zip>64200</zip>
        <telephone>+92 313 5969696</telephone>
        <email>nabeel4allz@gmail.com</email>
        <affiliation>Combined Military Hospital Rahim Yar Khan</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Nabeel Tahir Butt</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Chowk Bhadarpur</address>
        <city>Rahim Yar Khan</city>
        <country1>Pakistan</country1>
        <zip>64200</zip>
        <telephone>+92 313 5969696</telephone>
        <email>nabeel4allz@gmail.com</email>
        <affiliation>Combined Military Hospital Rahim Yar Khan</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Pakistan</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Included all ASA-II (American society of Anaesthesiologists) male and female patients above the age of fifty years
Requiring total hip arthroplasty (THA) due to advanced osteoarthritis of the hip joint.</inclusion_criteria>
      <agemin>50 years</agemin>
      <agemax>75 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Excluded patients with major cardiac or respiratory debility, metastatic bone disease, allergy to drugs used for the block, bleeding diathesis, coagulation defects, patients with patchy or failed block after administration and patients not willing to be included in the study.
Metastatic bone disease
Allergy to the drugs used in the block (lignocaine)
Bleeding diathesis and coagulation disorders
Patients with patchy or failed block after administration
Patients not willing to be included in the study</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M16</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Osteoarthritis of hip</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Group F (Fascia iliac block group) will receive the block pre-operatively in the operating room with the patient unaware of the block performed by a consultant anesthetist with at least 5 years of experience under ultrasound guidance administering 20 ml of local anesthetic (2% ligonicaine) in the facia iliac plane. After surgery median pain scores assessment would be done by standard visual analog scale at 3,6,12 and 24 hour duration along with time to patient mobilization</i_keyword>
      <i_keyword>Intervention group: Group P (pericapsular nerve group block) will receive the block pre-operatively in the operating room with the patient unaware of the block performed by a consultant anesthetist with at least 5 years of experience under ultrasound guidance administering 20 ml of local anesthetic (2% ligonicaine) in the pericapsular space and blocking corresponding nerves. After surgery median pain scores assessment would be done by standard visual analog scale at 3,6,12 and 24 hour duration along with time to patient mobilization</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Mean time for first dose of rescue analgesia and mean time to patient mobilization. Timepoint: Within 12 hours post-surgery. Method of measurement: Standard Visual Analog scale for pain assessment.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>None</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-08-01</approval_date>
        <contact_name>Ethical review board Combined Military Hospital Rahim Yar khan</contact_name>
        <contact_address>Chowk Bahadarpur Rahim Yar Khan Punjab Pakistan</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
